![John Stuelpnagel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Stuelpnagel
Vorsitzender bei
10X GENOMICS, INC.
Vermögen: 220 Mio $ am 30.09.2026
Profil
John R. Stuelpnagel ist ein Unternehmer und Geschäftsmann, der Illumina, Inc., Fabric Genomics, Inc. und Ariosa Diagnostics, Inc. gegründet hat und der an der Spitze von 6 verschiedenen Unternehmen stand. Er ist Vorsitzender bei 10X Genomics, Inc. und bei Fabric Genomics, Inc. sowie Vorsitzender bei Inscripta, Inc. und Element Biosciences, Inc. John R. Stuelpnagel ist außerdem Mitglied des Vorstands von Federation Bio, Inc. und Encoded Therapeutics, Inc. In der Vergangenheit hatte Dr. Stuelpnagel die Position des Chief Operating Officer & Director bei Illumina, Inc. inne, war Associate bei CW Group, Inc. und BRD bei Sequenta, Inc. und Executive Chairman von Ariosa Diagnostics, Inc. Er erwarb einen Doktortitel und einen Bachelor-Abschluss an der University of California, Davis und einen MBA an der University of California, Los Angeles.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
10X GENOMICS INC 10.47% | 31.03.2026 | 2’105’736 ( 10.47% ) | 190 Mio $ | 30.09.2026 |
| 03.09.2026 | 328’436 ( 0.27% ) | 30 Mio $ | 30.09.2026 |
Aktive Positionen von John Stuelpnagel
| Unternehmen | Position | Beginn |
|---|---|---|
| 10X GENOMICS, INC. | Vorsitzender | 01.08.2013 |
Fabric Genomics, Inc.
 Fabric Genomics, Inc. Packaged SoftwareTechnology Services Develops AI-powered genomic interpretation platform | Gründer | - |
Inscripta, Inc.
 Inscripta, Inc. BiotechnologyHealth Technology Develops digital genome engineering solutions | Vorsitzender | 01.04.2017 |
Encoded Therapeutics, Inc.
 Encoded Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops and manufactures disease-modifying gene therapies for pediatric central nervous system | Direktor/Vorstandsmitglied | 01.05.2017 |
Federation Bio, Inc.
 Federation Bio, Inc. BiotechnologyHealth Technology Research and develops micro biome therapeutics | Direktor/Vorstandsmitglied | 01.06.2020 |
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Berater | 01.01.1998 |
Ehemalige bekannte Positionen von John Stuelpnagel
| Unternehmen | Position | Ende |
|---|---|---|
Element Biosciences, Inc.
 Element Biosciences, Inc. Medical SpecialtiesHealth Technology Develops single-cell and spatial multiomics sequencing & reagent kits and related software solutions | Vorsitzender | 01.01.2023 |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Direktor/Vorstandsmitglied | 01.11.2017 |
Ariosa Diagnostics, Inc.
 Ariosa Diagnostics, Inc. Medical/Nursing ServicesHealth Services Offers diagnostics and genetic testing services | Gründer | 01.01.2015 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von John Stuelpnagel
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
84
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Venrock Associates
Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Finance |
Illumina, Inc.
 Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
Sequenta, Inc.
 Sequenta, Inc. BiotechnologyHealth Technology Operates as a biotech company which discovers and develops clinical diagnostics based on immune system status | Health Technology |
10X Genomics, Inc.
 10X Genomics, Inc. BiotechnologyHealth Technology Develops integrated systems and solutions for genome sequencing, exome sequencing and single cell transcriptomics | Health Technology |
CW Group, Inc.
 CW Group, Inc. Investment ManagersFinance CW Group invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fabric Genomics, Inc.
Fabric Genomics, Inc. Packaged SoftwareTechnology Services Develops AI-powered genomic interpretation platform | Technology Services |
Ariosa Diagnostics, Inc.
Ariosa Diagnostics, Inc. Medical/Nursing ServicesHealth Services Offers diagnostics and genetic testing services | Health Services |
Adaptive Biotechnologies Corp.
 Adaptive Biotechnologies Corp. BiotechnologyHealth Technology Develops minimal residual disease and immune medicine | Health Technology |
Inscripta, Inc.
Inscripta, Inc. BiotechnologyHealth Technology Develops digital genome engineering solutions | Health Technology |
Federation Bio, Inc.
Federation Bio, Inc. BiotechnologyHealth Technology Research and develops micro biome therapeutics | Health Technology |
Element Biosciences, Inc.
Element Biosciences, Inc. Medical SpecialtiesHealth Technology Develops single-cell and spatial multiomics sequencing & reagent kits and related software solutions | Health Technology |
Encoded Therapeutics, Inc.
Encoded Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops and manufactures disease-modifying gene therapies for pediatric central nervous system | Health Technology |
